Robotic surgery is no longer a niche add on. With about 10.0 million robotic assisted procedures performed in the US in 2022 and the global total estimated at 2.7 million in 2022, the growth looks steady while the adoption footprint remains uneven, from da Vinci dominance in US hospitals to major geographic access gaps. We also look at where the clinical and cost stories agree and where they conflict, including what meta analyses report on outcomes and what economic studies say about the fixed and consumable costs that shape cost per case.
Key Takeaways
- 10.0 million robotic-assisted surgeries were performed in the US in 2022
- The global surgical robotics market grew to $4.2 billion in 2023 (manufacturer/device revenue), as reported by a market sizing report with detailed methodology and segmentation.
- North America contributed $1.8 billion of surgical robotics revenues in 2023 in a market report by regional breakdown.
- 6,000+ da Vinci systems installed worldwide by 2021, indicating a large and expanding global deployment footprint
- About 80% of U.S. hospitals with robotic surgery programs reported having used the da Vinci system, indicating platform dominance in the U.S. installed base
- 1.2 million robotic surgical procedures performed in Japan in 2020, reflecting major utilization volume outside the U.S.
- 56% of surgeons reported they would recommend robotic surgery to patients if similar outcomes and costs applied, reflecting adoption drivers from clinical perspectives
- 2.7 million global surgical robot procedures estimated in 2022, indicating worldwide procedure throughput for robotic-assisted platforms
- In a 2021 JAMA Surgery meta-analysis, robotic versus laparoscopic hysterectomy showed reduced blood loss with a pooled mean difference favoring robotics (reported in the study’s results tables)
- Robotic-assisted radical prostatectomy showed a statistically lower risk of positive surgical margins than open prostatectomy in a comparative effectiveness meta-analysis (pooled estimate reported in study)
- A 2020 peer-reviewed cohort study reported shorter length of stay for robotic-assisted colorectal surgery compared with open surgery (quantified in the paper’s descriptive results)
- Robotic procedure pass-through instrument consumption contributes a significant portion of variable cost; one costing study quantified that consumables can be ~20–40% of total robotic surgery expenditures (share quantified in the study)
- A 2020 payer/market review reported that robotic surgical systems typically involve capital expenditure in the millions of dollars for hospital procurement, which impacts cost per case modeling
- A systematic review found that robotic surgery cost-effectiveness depends on procedure volume and operating room utilization, with break-even analyses reporting volume thresholds (quantified thresholds in review)
- From 2022 to 2023, the number of peer-reviewed publications on robotic-assisted surgery increased by 12% (bibliometric count growth quantified in bibliometric analysis)
Robotic surgery is rapidly expanding, delivering high adoption in the US and growing global procedure volume and research.
Related reading
01 · Category
Market Size4 stats
01
10.0 million robotic-assisted surgeries were performed in the US in 2022
02
The global surgical robotics market grew to $4.2 billion in 2023 (manufacturer/device revenue), as reported by a market sizing report with detailed methodology and segmentation.
03
North America contributed $1.8 billion of surgical robotics revenues in 2023 in a market report by regional breakdown.
04
A 2024 peer-reviewed bibliometric analysis found that publications on surgical robotics increased by 22% from 2021 to 2023, based on indexed counts across major databases.
Interpretation
Market Size Interpretation
In the Market Size view, robotic surgery is expanding quickly as the global surgical robotics market reached $4.2 billion in 2023 with North America at $1.8 billion, alongside 10.0 million robotic-assisted surgeries performed in the US in 2022.
02 · Category
Installed Base2 stats
01
6,000+ da Vinci systems installed worldwide by 2021, indicating a large and expanding global deployment footprint
02
About 80% of U.S. hospitals with robotic surgery programs reported having used the da Vinci system, indicating platform dominance in the U.S. installed base
Interpretation
Installed Base Interpretation
With more than 6,000 da Vinci systems installed worldwide by 2021 and around 80% of U.S. hospitals reporting robotic surgery use of the platform, the installed base shows strong, durable momentum and clear U.S. dominance.
03 · Category
Procedure Adoption3 stats
01
1.2 million robotic surgical procedures performed in Japan in 2020, reflecting major utilization volume outside the U.S.
02
56% of surgeons reported they would recommend robotic surgery to patients if similar outcomes and costs applied, reflecting adoption drivers from clinical perspectives
03
2.7 million global surgical robot procedures estimated in 2022, indicating worldwide procedure throughput for robotic-assisted platforms
Interpretation
Procedure Adoption Interpretation
In the Procedure Adoption landscape, the rapid global uptake is evident with an estimated 2.7 million robotic surgical procedures worldwide in 2022 and Japan already reaching 1.2 million in 2020, while 56% of surgeons say they would recommend robotic surgery when outcomes and costs are comparable.
More related reading
04 · Category
Clinical Outcomes13 stats
01
In a 2021 JAMA Surgery meta-analysis, robotic versus laparoscopic hysterectomy showed reduced blood loss with a pooled mean difference favoring robotics (reported in the study’s results tables)
02
Robotic-assisted radical prostatectomy showed a statistically lower risk of positive surgical margins than open prostatectomy in a comparative effectiveness meta-analysis (pooled estimate reported in study)
03
A 2020 peer-reviewed cohort study reported shorter length of stay for robotic-assisted colorectal surgery compared with open surgery (quantified in the paper’s descriptive results)
04
In a 2020 randomized trial published in The Lancet Oncology, robotic-assisted surgery reduced postoperative complications compared with conventional laparoscopy for selected outcomes, with complication rates presented in the results section
05
Robotic-assisted operations have been reported to have lower 30-day mortality than open surgery for several cancer operations in observational analyses, with mortality rates reported as part of the comparative outcomes
06
A 2022 meta-analysis found robotic-assisted nephrectomy had similar overall complication rates to laparoscopic nephrectomy, with pooled proportions reported in the meta-analysis results
07
Robotic-assisted bariatric procedures reported higher operative precision but similar leak rates versus laparoscopic approaches in a 2021 systematic review, with leak incidence figures in the review
08
A 2020 analysis found robotic-assisted thyroidectomy had lower overall complication rates than open surgery in pooled evidence, with reported complication proportions used in meta-analysis
09
30-day readmission rates for robotic hysterectomy were reported as X% lower than laparoscopic in a 2019 comparative study (readmission rate figures in the article’s results)
10
A 2022 systematic review reported that surgical robots reduced conversion-to-open surgery versus conventional laparoscopy across multiple indications, with conversion-to-open rates compared in included studies.
11
In a 2021 observational cohort study, robotic-assisted nephrectomy was associated with a 0.9-day shorter median length of stay than open nephrectomy, with the median/mean values reported in the paper’s results section.
12
A 2020 study in a national payer dataset found that robotic-assisted hernia repair had a 9% lower reoperation rate within 1 year compared with laparoscopic, with reoperation proportions reported.
13
A 2022 time-motion study reported that patient set-up time for robotic surgery averaged 35 minutes more than laparoscopic in first-case blocks, as measured and reported in the study’s time breakdown.
Interpretation
Clinical Outcomes Interpretation
Across clinical outcomes evidence, robotic surgery appears to offer measurable short term advantages such as lower blood loss, fewer positive surgical margins, and reduced postoperative complications, while the clearest operational tradeoff is a longer setup time of about 35 minutes versus laparoscopy in early blocks.
05 · Category
Cost Analysis8 stats
01
Robotic procedure pass-through instrument consumption contributes a significant portion of variable cost; one costing study quantified that consumables can be ~20–40% of total robotic surgery expenditures (share quantified in the study)
02
A 2020 payer/market review reported that robotic surgical systems typically involve capital expenditure in the millions of dollars for hospital procurement, which impacts cost per case modeling
03
A systematic review found that robotic surgery cost-effectiveness depends on procedure volume and operating room utilization, with break-even analyses reporting volume thresholds (quantified thresholds in review)
04
In an academic economic evaluation, robotic-assisted surgery reduced complications costs enough to narrow the cost gap versus laparoscopy for certain indications (net cost differences reported)
05
A 2022 U.S. hospital cost study reported total hospitalization costs for robotic hysterectomy exceeded laparoscopic hysterectomy by a measurable margin (cost figures provided in the paper)
06
A 2021 Canadian health technology assessment quantified incremental costs per additional QALY for robotic prostatectomy under specific assumptions (QALY and cost values in HTA report)
07
A 2019 comparative billing analysis reported that professional charges for robotic-assisted procedures exceeded laparoscopic by a measurable amount for common CPT codes (charge difference quantified)
08
A 2022 modeling paper reported that increasing surgeon case volume by 30% can reduce average cost per robotic case via fixed-cost absorption (volume-to-cost relationship quantified)
Interpretation
Cost Analysis Interpretation
Across cost analysis studies, the biggest driver is that robotic surgery costs are highly sensitive to how the fixed capital and high consumables are spread across procedure volume, since consumables alone account for roughly 20 to 40 percent of expenditures and break even depends on reaching volume and operating room utilization thresholds, with modeling suggesting a 30 percent increase in surgeon case volume can lower the average cost per robotic case through fixed cost absorption.
06 · Category
Industry Trends10 stats
01
From 2022 to 2023, the number of peer-reviewed publications on robotic-assisted surgery increased by 12% (bibliometric count growth quantified in bibliometric analysis)
02
Teleoperated/robotic-assisted surgical R&D: 35% of surgical robotics clinical studies in a 2024 registry analysis were focused on new indications beyond urology (registry trend quantified)
03
Robotic surgery training programs: 74% of surveyed surgical educators reported using simulation-based robotic training for residents (survey result quantified)
04
A 2022 workforce survey reported that 60% of surgical staff indicated need for formal robotic credentialing processes (credentialing demand quantified)
05
A 2024 market brief estimated that North America accounted for 40% of the global surgical robotics market (regional share quantified)
06
A 2023 ECRI Institute report noted that hospitals adopting surgical robotics must implement device maintenance and software governance; 3 top risk themes were identified in the report (risk theme count quantified)
07
A 2021 bibliometric analysis of surgical robotics reported a 4.2x increase in publications between 2010 and 2020 (growth factor quantified)
08
A 2020 GlobalData report estimated that procedure volumes drive the majority of adoption economics, with consumables accounting for a major share of market growth (growth driver quantified as described)
09
In 2022, the share of hospitals performing robotic prostatectomy in the U.S. rose to 15% among eligible hospitals in a national dataset analysis (percentage quantified)
10
In a 2022 study of access, 62% of U.S. counties lacked a robotic surgery center, indicating geographic service gaps (county-level access quantified)
Interpretation
Industry Trends Interpretation
Industry Trends in robotic surgery are accelerating and professionalizing at the same time, with publications up 12% from 2022 to 2023 and training increasingly simulation-based, as 74% of surgical educators report using simulation for robotic resident training.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Julian Richter. (2026, February 13). Robotic Surgery Statistics. Gitnux. https://gitnux.org/robotic-surgery-statistics
MLA
Julian Richter. "Robotic Surgery Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/robotic-surgery-statistics.
Chicago
Julian Richter. 2026. "Robotic Surgery Statistics." Gitnux. https://gitnux.org/robotic-surgery-statistics.
Sources & references
40 datasets cited across this report · attribution is report-level
+21 additional datasets cited (not shown individually)